Leonard S. Schleifer

2013

In 2013, Leonard S. Schleifer earned a total compensation of $36.3M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 21% increase compared to previous year.

Compensation breakdown

Bonus$2,070,000
Option Awards$33,062,325
Salary$1,035,000
Other$105,340
Total$36,272,665

Schleifer received $33.1M in option awards, accounting for 91.15% of the total pay in 2013.

Schleifer also received $2.1M in bonus, $1M in salary and $105.3K in other compensation.

Overall ranking

Ranking

23

out of 12,114
Percentile100th

Leonard S. Schleifer's 2013 compensation ranked 23rd out of 12,114 executive pay records tracked by us this year.

Schleifer earned more than 99.8% of all executives tracked by us in 2013.

Ranking in industry group

Industry groupDrugs
Ranking

2

out of 1,115
Percentile100th

In the industry group of Drugs, Schleifer's pay ranked 2nd out of 1,115 executive pay records tracked by us in 2013.

Schleifer earned more than 99.8% of executives in this group.

Source: SEC filing on April 26, 2016.

Schleifer's colleagues

We found five more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2013.

2013

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2013

Neil Stahl

Regeneron Pharmaceuticals

Executive Vice President, Research & Development

2013

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

2013

Robert Terifay

Regeneron Pharmaceuticals

Executive Vice President, Commercial

2013

Murray Goldberg

Regeneron Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like